Wordt geladen...
Dipeptidyl peptidase-4 and kidney fibrosis in diabetes
Diabetic nephropathy (DN) is the most common cause of end-stage kidney disease worldwide and is associated with increased morbidity and mortality in patients with both type 1 and type 2 diabetes. Recent evidence revealed that dipeptidyl peptidase-4 (DPP-4) inhibitors may exhibit a protective effect...
Bewaard in:
| Gepubliceerd in: | Fibrogenesis Tissue Repair |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4752740/ https://ncbi.nlm.nih.gov/pubmed/26877767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13069-016-0038-0 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|